ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report)’s share price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $3.31 and traded as high as $3.67. ZIVO Bioscience shares last traded at $3.67, with a volume of 1,127 shares changing hands.
ZIVO Bioscience Stock Up 8.7%
The firm has a 50 day moving average of $3.31 and a 200 day moving average of $7.11. The firm has a market cap of $15.24 million, a PE ratio of -0.75 and a beta of 0.07.
About ZIVO Bioscience
ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.
Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.
Further Reading
- Five stocks we like better than ZIVO Bioscience
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
